Solara Pharma Share Price: Company ne **₹17 Cr** ka Loss Report kiya, Paise ki Zaroorat Kyun?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Solara Pharma Share Price: Company ne **₹17 Cr** ka Loss Report kiya, Paise ki Zaroorat Kyun?
Overview

Solara Active Pharma ke liye Q3 FY26 ka result bohot bura aaya hai. Company ne is quarter mein **₹17.43 Crore** ka bada consolidated net loss report kiya hai, jabki pichhle saal isi time profit tha. Revenue toh badh raha hai, par company paise ki mushkil mein hai aur fundraising kar rahi hai.

📉 Achanak company red mein kaise chali gayi?

Dekho, Solara Active Pharma Sciences ne Q3 FY26 ke liye jo numbers diye hain, woh thode pareshan karne wale hain. Quarter ended December 31, 2025 tak, company ka consolidated revenue ₹349 Crore raha. Yeh pichhle quarter se 11.31% zyada hai aur pichhle saal ke same quarter se bhi 16.21% zyada hai. Toh achhi khabar yeh hai ki revenue growth achhi hai.

Par profit kahan hai?

Asal problem yahi hai. Revenue itna badhne ke baad bhi, company ₹17.43 Crore ke consolidated net loss mein chali gayi. Pichhle saal Q3 FY25 mein isi time company ₹8.10 Crore ka profit kama rahi thi. Aur agar last nine months ki baat karein, toh loss badhkar ₹17.01 Crore ho gaya hai.

Loss ka ek bada reason?

Ek exceptional item loss bhi tha ₹6.75 Crore ka, jo naye labour codes ke under gratuity aur compensated absences ki wajah se hua. Iss sab ke baad, Q3 FY26 mein basic aur diluted EPS (₹3.98) negative mein chala gaya.

Ab company ki asli haalat kya hai?

As of December 31, 2025, Solara Pharma ke upar total accumulated losses ₹329.64 Crore ho gaye hain. Aur current liabilities, current assets se ₹92.44 Crore zyada hain. Matlab jeb mein paise kam aur dene zyada hain. Is wajah se, company ke board ne kaha hai ki results ko 'going concern' basis par banaya gaya hai.

Toh ab hoga kya?

Company ne board ne decide kiya hai ki woh ₹134.99 Crore rights issue ke through raise karenge taaki operations chalte rahein. Yeh sab tab hoga jab working capital facilities renew hongi aur revenue/margins badhein. Management abhi future growth se zyada immediate paison par focus kar raha hai.

🚩 Risks aur aage kya dekhna hai?

Sabse bada risk toh yahi hai ki company ke paas paise kam hain. Agar rights issue se paise nahi aaye ya working capital facilities renew nahi hui toh company band bhi ho sakti hai. Profitability ko wapas lane ka pressure bhi bohot hai. Investors ko abhi rights issue ka result aur working capital renewal par nazar rakhni hogi. Company agar debt manage nahi kar payi toh situation aur kharab ho sakti hai.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.